| http://www.w3.org/ns/prov#value | - Reductions in HbA1c were seen across subgroups including gender, age, race, duration of disease, and baseline BMI. 14.2 Monotherapy A total of 840 treatment-naive patients with inadequately controlled type 2 diabetes participated in 2 placebo-controlled studies to evaluate the safety and efficacy of monotherapy with FARXIGA. In 1 monotherapy study, a total of 558 treatment-naive patients with inad
|
